m6A甲基化修饰的lncRNA对消化道肿瘤的作用
Role of m6A Methylation-Modified lncRNA in Digestive Tract Tumors
DOI: 10.12677/hjbm.2025.151013, PDF,    国家自然科学基金支持
作者: 马垲森, 王小平*：西藏民族大学医学院，陕西 咸阳
关键词: m6A甲基化修饰；IncRNA；治疗；消化道肿瘤；生物标志物；m6A Methylation Modification； IncRNA； Therapy； Digestive Tract Tumors； Biomarkers
摘要: m6A甲基化是mRNA和lncRNA等RNA分子中的一种重要表观遗传修饰，通过调控基因表达，在消化道肿瘤的发生和发展中发挥重要作用。m6A甲基化修饰的lncRNA对多种消化道肿瘤如肝癌、胃癌、食管癌和胰腺癌的增殖、侵袭及转移有显著影响。在消化道肿瘤的诊断、治疗和预后评估中，m6A修饰的lncRNA作为生物标志物具有广泛应用潜力。未来的研究有望将这一修饰机制转化为临床治疗靶点，提升患者生存率和治疗效果。
Abstract: m6A methylation is an important epigenetic modification in RNA molecules such as mRNA and lncRNA, which plays an important role in the occurrence and development of gastrointestinal tumors by regulating gene expression. m6A methylation-modified lncRNA has a significant impact on the proliferation, invasion, and metastasis of a variety of gastrointestinal tract tumors such as hepatocellular carcinomas, gastric carcinomas, esophageal carcinomas, and pancreatic carcinomas. The m6A-modified lncRNA has a wide potential for use as biomarkers in the diagnosis, treatment and prognosis evaluation of GI tumors. Future studies are expected to translate this modification mechanism into clinical therapeutic targets to enhance patient survival and treatment effects.
文章引用：马垲森, 王小平. m6A甲基化修饰的lncRNA对消化道肿瘤的作用[J]. 生物医学, 2025, 15(1): 117-125. https://doi.org/10.12677/hjbm.2025.151013

参考文献

[1] Zheng, W., Fu, Z., Tan, X., Liang, X. and Cao, L. (2024) Bioinformatic Analysis of m6A Regulator-Mediated RNA Methylation Modification Patterns and Immune Microenvironment Characterization in Endometriosis. Biochemical Genetics. [Google Scholar] [CrossRef] [PubMed]
[2] Harrold, E.C. and Stadler, Z.K. (2024) Upper Gastrointestinal Cancers and the Role of Genetic Testing. Hematology/Oncology Clinics of North America, 38, 677-691. [Google Scholar] [CrossRef] [PubMed]
[3] Lier, S., Sellmer, A., Orben, F., Heinzlmeir, S., Krauß, L., Schneeweis, C., et al. (2024) Corrigendum to “a Novel Cereblon E3 Ligase Modulator with Antitumor Activity in Gastrointestinal Cancer” [Bioorgan. Chem. 119 (2022) 105505]. Bioorganic Chemistry, 146, Article ID: 107248. [Google Scholar] [CrossRef] [PubMed]
[4] Lu, J., Li, H., Yu, Z., Cao, C., Xu, Z., Peng, L., et al. (2024) Cathepsin B as a Key Regulator of Ferroptosis in Microglia Following Intracerebral Hemorrhage. Neurobiology of Disease, 194, Article ID: 106468. [Google Scholar] [CrossRef] [PubMed]
[5] Xu, C., Xu, M.K., Hu, Y.X., et al. (2024) Ingestible Artificial Urinary Biomarker Probes for Urine Test of Gastrointestinal Cancer. Advanced Materials (Deerfield Beach, Fla.), 36, e2314084.
[6] Yoo, J.W., Laszkowska, M. and Mendelsohn, R.B. (2024) The Role of Screening and Early Detection in Upper Gastro-intestinal Cancers. Hematology/Oncology Clinics of North America, 38, 693-710.
[7] Jahani, M., Esmaeili, R., Abbasi, M., Nikbakht, H., Azarbakhsh, H., Roshandel, G., et al. (2024) Burden of Upper Gastrointestinal Cancers in the East of Golestan Province (Golestan Cohort Study). Cancer Reports, 7, e2001. [Google Scholar] [CrossRef] [PubMed]
[8] Freeman, H.D., Saunders, A.C. and Lum, S.S. (2024) COVID-19 Pandemic-Related Outcomes in High-Risk Gastrointestinal Cancers—Beyond the Numbers. JAMA Network Open, 7, e240143. [Google Scholar] [CrossRef] [PubMed]
[9] Arshad, J., Rao, A., Repp, M.L., Rao, R., Wu, C. and Merchant, J.L. (2024) Myeloid-Derived Suppressor Cells: Therapeutic Target for Gastrointestinal Cancers. International Journal of Molecular Sciences, 25, Article No. 2985. [Google Scholar] [CrossRef] [PubMed]
[10] Wang, C. and Niu, Y. (2024) Knowledge and Awareness of Early Gastrointestinal Cancer Screening in Sunan Yugur Autonomous County in Gansu, China. Journal of International Medical Research, 52, 1-8. [Google Scholar] [CrossRef] [PubMed]
[11] Zhang, M., Yang, C.B., Dong, W., Zhao, Y.T., Chen, N. and Gao, C.G. (2024) Expression Patterns and Prognostic Role of M6a RNA Methylation Regulators in Non-Small Cell Lung Cancer. Cellular and Molecular Biology, 70, 67-72. [Google Scholar] [CrossRef] [PubMed]
[12] Zhu, C., Yang, J., Zhang, C., Wang, Y. and Wang, J. (2024) Knowledge Mapping and Current Trends of m6A Methylation in the Field of Cancer. Heliyon, 10, e26262. [Google Scholar] [CrossRef] [PubMed]
[13] Hong, L., Zhuo, T. and Jing, S. (2024) Silencing of METTL3 Inhibits M6a Methylation of NEK7 to Suppress Pyrolysis in an HT-22 Cell-Based Model of Intracerebral Hemorrhage. Brain Research, 1831, Article ID: 148828. [Google Scholar] [CrossRef] [PubMed]
[14] Zhang, C., Huang, Y., Liang, M., Wu, J. and Wang, G. (2024) Characterization of m6a RNA Methylation Mediated Immune Heterogeneity and Functional Validation in Hepatocellular carcinoma. Environmental Toxicology. [Google Scholar] [CrossRef] [PubMed]
[15] Bao, T.P., Zhu, H.Y., Ma, M.M., et al. (2024) Implication of m6A Methylation Regulators in the Immune Microenvironment of Bronchopulmonary Dysplasia. Biochemical Genetics.
[16] Leonetti, A.M., Galluzzo, I.R., McLean, T.A.D., Stefanelli, G., Ramnaraign, F., Holm, S., et al. (2024) The Role of the m6A/m Demethylase FTO in Memory Is both Task and Sex-Dependent in Mice. Neurobiology of Learning and Memory, 210, Article ID: 107903. [Google Scholar] [CrossRef] [PubMed]
[17] Baba, Y., Yasuda, N., Bundo, M., Nakachi, Y., Ueda, J., Ishimoto, T., et al. (2023) Line‐1 Hypomethylation, Increased Retrotransposition and Tumor‐Specific Insertion in Upper Gastrointestinal Cancer. Cancer Science, 115, 247-256. [Google Scholar] [CrossRef] [PubMed]
[18] 凌晨. 食管癌的m6A调节因子介导的甲基化调控模式和肿瘤微环境浸润特征[D]: [硕士学位论文]. 十堰: 湖北医药学院, 2023.
[19] Peng, C., Zhao, G., Pei, B., Wang, K., Li, H., Fei, S., et al. (2022) A Novel Plasma-Based Methylation Panel for Upper Gastrointestinal Cancer Early Detection. Cancers, 14, Article No. 5282. [Google Scholar] [CrossRef] [PubMed]
[20] Camuzi, D., Buexm, L.A., Lourenço, S.d.Q.C., Grazziotin, R., Guaraldi, S., Valverde, P., et al. (2022) FBXL7 Body Hypomethylation Is Frequent in Tumors from the Digestive and Respiratory Tracts and Is Associated with Risk-Factor Exposure. International Journal of Molecular Sciences, 23, Article No. 7801. [Google Scholar] [CrossRef] [PubMed]
[21] Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A. and Jemal, A. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. [Google Scholar] [CrossRef] [PubMed]
[22] Liu, Z., Li, S., Huang, S., Wang, T. and Liu, Z. (2021) N6-Methyladenosine Regulators and Related LncRNAs Are Potential to Be Prognostic Markers for Uveal Melanoma and Indicators of Tumor Microenvironment Remodeling. Frontiers in Oncology, 11, Article 704543. [Google Scholar] [CrossRef] 
[23] Jarroux, J., Foretek, D., Bertrand, C., Gabriel, M., Szachnowski, U., Saci, Z., et al. (2021) HOTAIR LncRNA Promotes Epithelial-Mesenchymal Transition by Redistributing LSD1 at Regulatory Chromatin Regions. EMBO Reports, 22, e50193. [Google Scholar] [CrossRef] [PubMed]
[24] Soares-Lima, S.C., Mehanna, H., Camuzi, D., de Souza-Santos, P.T., Simão, T.d.A., Nicolau-Neto, P., et al. (2021) Upper Aerodigestive Tract Squamous Cell Carcinomas Show Distinct Overall DNA Methylation Profiles and Different Molecular Mechanisms behind WNT Signaling Disruption. Cancers, 13, Article No. 3014. [Google Scholar] [CrossRef] [PubMed]
[25] 张璐瑶, 汪丽钰, 陈乾, 时建明. m6A甲基化修饰与消化道恶性肿瘤关系的研究进展[J]. 医学综述, 2021, 27(9): 1753-1758.
[26] 宋海飞, 余诗俊, 高勇. m6A甲基化在多种消化道肿瘤中的研究进展[J]. 现代肿瘤医学, 2020, 28(20): 3613-3616.
[27] Hasan, M., Nishat, Z.S., Hasan, M.S., Hossain, T. and Ghosh, A. (2024) Identification of m6A RNA Methylation Genes in Oryza sativa and Expression Profiling in Response to Different Developmental and Environmental Stimuli. Biochemistry and Biophysics Reports, 38, Article ID: 101677. [Google Scholar] [CrossRef] [PubMed]
[28] Zhang, Z., Zhang, L., Li, J., Feng, R., Li, C., Liu, Y., et al. (2024) Comprehensive Analysis of m6A Methylome Alterations after Azacytidine plus Venetoclax Treatment for Acute Myeloid Leukemia by Nanopore Sequencing. Computational and Structural Biotechnology Journal, 23, 1144-1153. [Google Scholar] [CrossRef] [PubMed]
[29] Qiu, M., Chen, Y. and Zeng, C. (2024) Biological Functions of circRNA in Regulating the Hallmarks of Gastrointestinal Cancer (Review). International Journal of Oncology, 64, Article No. 49. [Google Scholar] [CrossRef] [PubMed]
[30] Colloca, G.A. and Venturino, A. (2024) The Prognosis of Metastatic Gastrointestinal Cancer. CRC Press. [Google Scholar] [CrossRef] 
[31] Wang, D., Bao, S., Song, N., Chen, W., Ding, X., Walker, R.J., et al. (2024) FTO-Mediated m6A mRNA Demethylation Aggravates Renal Fibrosis by Targeting RUNX1 and Further Enhancing PI3K/AKT Pathway. The FASEB Journal, 38, e23436. [Google Scholar] [CrossRef] [PubMed]
[32] Wei, R., Zhao, F., Kong, L., Pu, Y., Li, Y. and Zang, C. (2024) The Antagonistic Effect of FTO on METTL14 Promotes AKT3 m6A Demethylation and the Progression of Esophageal Cancer. Journal of Cancer Research and Clinical Oncology, 150, Article No. 131. [Google Scholar] [CrossRef] [PubMed]
[33] Fang, W., Peng, P., Lin, K., Xiao, F., He, W., He, M., et al. (2024) M6A Methylation Modification and Immune Infiltration Analysis in Osteonecrosis of the Femoral Head. Journal of Orthopaedic Surgery and Research, 19, Article No. 183. [Google Scholar] [CrossRef] [PubMed]
[34] Li, X., Zhang, Y., Guo, S., Wu, Z., Wang, H., Huang, Y., et al. (2024) Global Analysis of T-Cell Groups Reveals Immunological Features and Common Antigen Targets of Digestive Tract Tumors. Journal of Cancer Research and Clinical Oncology, 150, Article No. 129. [Google Scholar] [CrossRef] [PubMed]
[35] Qin, R.F., Huang, M.H., Jiang, Y., Jiang, D., Chang, D.D., Xie, Y.F., et al. (2024) N6-Methyladenosine (m6A) Sequencing Reveals Heterodera glycines-Induced Dynamic Methylation Promoting Soybean Defense. Phytopathology, 114, 1612-1625.

为你推荐